Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL11587603 | 1.00 | ALDH1A1 (0.75) | — | |
| Isopropyl Alcohol SCHEMBL5815842 | 1.00 | — | — | |
| Isopropyl Alcohol SCHEMBL18492877 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL9066428 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL9317726 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL1236799 | 0.94 | ALDH1A1 (0.86) | — | |
| Isopropyl Alcohol SCHEMBL3680075 | 0.94 | ALDH1A1 (0.86) | — | |
| Isopropyl Alcohol SCHEMBL28380595 | 0.94 | ALDH1A1 (0.86) | — | |
| Isopropyl Alcohol SCHEMBL22773 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL42097 | 0.94 | ALDH1A1 (0.86) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109706193-A | Vitamin K in a kind of enrichment bacillus natto to ferment liquid2Method | 中国科学院合肥物质科学研究院 | 2019-05-03 | — | — | CN | claimed |
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | MIRATI THERAPEUTICS INC (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024026423-A1 | SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024026424-A1 | QUINAZOLINONE DERIVATIVES AS AND RELATED USES | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-4304720-A1 | MTA-COOPERATIVE PRMT5 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023150186-A1 | DGK TARGETING COMPOUNDS AND USES THEREOF | ARVINAS OPERATIONS, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230026616-A1 | PYRIMIDOIMIDAZOLE COMPOUNDS USED AS DNA-PK INHIBITORS | ZAI LAB (SHANGHAI) CO., LTD (CN) | 2023-01-26 | — | — | US | disclosed |
| CN-111201229-A | Bicyclic compounds useful as RIP1 kinase inhibitors | 豪夫迈·罗氏有限公司 | 2020-05-26 | — | — | CN | disclosed |
| CN-110234638-A | Heteroaryl phenoxy benzamide KAPPA opiates ligand | 辉瑞大药厂 | 2019-09-13 | — | — | CN | disclosed |
| CN-110182770-A | Preparation method of hydrophobic hexagonal boron nitride nanosheet | 苏州太湖电工新材料股份有限公司 | 2019-08-30 | — | — | CN | disclosed |
| US-4271153-A | VIRICIDES - TO COMBAT HERBES VIRUS | ROBUGEN GMBH PHARMAZEUTISCHE FABRIK (DE) | 1981-06-02 | — | — | US | disclosed |
| WO-1981000716-A1 | REACTIVE LIQUID POLYMERS | GOODRICH CO B F (US) | 1981-03-19 | — | — | WO | disclosed |
| US-4256910-A | AN EPIHALOHYDRIN POLYMER ENDCAPPED WITH AN HYDROXYALKYL ACRYLATE OR METHACRYLATE; TOUGHNESS AFTER CURING | THE B. F. GOODRICH COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4252803-A | HYPOTENSIVE AGENTS, ANALGESICS | GLAXO GROUP LIMITED (GB) | 1981-02-24 | — | — | US | disclosed |
| US-4199570-A | AZETIDINE, PYRROLIDINE, OR PIPERIDINE | SHIONOGI & CO., LTD. (JP) | 1980-04-22 | — | — | US | disclosed |
| US-4160015-A | 2,4,6-Triiodobenzoic acid derivatives and their use as x-ray contrast agents | MALLINCKRODT, INC. (US) | 1979-07-03 | — | — | US | disclosed |
| US-4154821-A | BIOSYNTHESIS; ANTIINFLAMMATORY AGENTS AND IMMUNOSTIMULATING AGENTS | ROUSSEL UCLAF (FR) | 1979-05-15 | — | — | US | disclosed |
| EP-0001280-A2 | 1-N-acylated-4-O-glycosyl-6-O-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them | SHIONOGI & CO., LTD. (JP) | 1979-04-04 | — | — | EP | disclosed |
| US-4125599-A | 2,4,6-TRIIODO-AMIDO-BENZOIC ACIDS | MALLINCKRODT, INC. (US) | 1978-11-14 | — | — | US | disclosed |
| US-4053591-A | 5-DEOXY-4,6-DI-O-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, METHODS FOR THEIR MANUFACTURE, METHOD FOR THEIR USE AS ANTIBACTERIAL AGENTS AND COMPOSITIONS USEFUL THEREFOR | SCHERING CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |